121 related articles for article (PubMed ID: 7951516)
21. Effect of continuous combined estrogen and desogestrel hormone replacement therapy on serum lipids and lipoproteins.
Marsh MS; Crook D; Whitcroft SI; Worthington M; Whitehead MI; Stevenson JC
Obstet Gynecol; 1994 Jan; 83(1):19-23. PubMed ID: 8272301
[TBL] [Abstract][Full Text] [Related]
22. The rebound of lipoproteins after LDL-apheresis. Kinetics and estimation of mean lipoprotein levels.
Kroon AA; van't Hof MA; Demacker PN; Stalenhoef AF
Atherosclerosis; 2000 Oct; 152(2):519-26. PubMed ID: 10998482
[TBL] [Abstract][Full Text] [Related]
23. Lp(a) levels and atherosclerotic vascular disease in a sample of patients with familial hypercholesterolemia sharing the same gene defect.
Carmena R; Lussier-Cacan S; Roy M; Minnich A; Lingenhel A; Kronenberg F; Davignon J
Arterioscler Thromb Vasc Biol; 1996 Jan; 16(1):129-36. PubMed ID: 8548413
[TBL] [Abstract][Full Text] [Related]
24. Effect of testosterone enanthate on serum lipoproteins in man.
Anderson RA; Wallace EM; Wu FC
Contraception; 1995 Aug; 52(2):115-9. PubMed ID: 8536448
[TBL] [Abstract][Full Text] [Related]
25. LDL-apheresis significantly reduces urinary apo(a) excretion.
Kostner KM; Jansen M; Maurer G; Derfler K
Eur J Clin Invest; 1997 Jan; 27(1):93-5. PubMed ID: 9041383
[TBL] [Abstract][Full Text] [Related]
26. Serum Lp(a) lipoprotein levels in patients with atherosclerotic occlusive disease of the lower extremities.
Dionyssiou-Asteriou A; Papastamatiou M; Vatalas I; Bastounis E
Eur J Vasc Endovasc Surg; 2000 Jul; 20(1):57-60. PubMed ID: 10906299
[TBL] [Abstract][Full Text] [Related]
27. Serum lipids, lipoprotein lp(a), and plasminogen activator inhibitor-1 in patients with Turner's syndrome before and during growth hormone and estrogen therapy.
Lanes R; Gunczler P; Palacios A; Villaroel O
Fertil Steril; 1997 Sep; 68(3):473-7. PubMed ID: 9314917
[TBL] [Abstract][Full Text] [Related]
28. Changes in serum lipoprotein(a) and lipids during treatment of hyperthyroidism.
Kung AW; Pang RW; Lauder I; Lam KS; Janus ED
Clin Chem; 1995 Feb; 41(2):226-31. PubMed ID: 7874776
[TBL] [Abstract][Full Text] [Related]
29. Different effects of continuous and intermittent patterns of growth hormone administration on lipoprotein levels in growth hormone-deficient patients.
Laursen T; Lemming L; Jørgensen JO; Klausen IC; Christiansen JS
Horm Res; 1998; 50(5):284-91. PubMed ID: 9873197
[TBL] [Abstract][Full Text] [Related]
30. The effect of growth hormone on low-density lipoprotein cholesterol and lipoprotein (a) levels in familial hypercholesterolemia.
Tonstad S; Sundt E; Ose L; Hagve TA; Fruchart JC; Bard JM; Edén S
Metabolism; 1996 Nov; 45(11):1415-21. PubMed ID: 8931648
[TBL] [Abstract][Full Text] [Related]
31. Lipoprotein (a) in patients with psoriasis: associations with lipid profiles and disease severity.
Pietrzak A; Kadzielewski J; Janowski K; Roliński J; Krasowska D; Chodorowska G; Paszkowski T; Kapeć E; Jastrzebska I; Tabarkiewicz J; Lotti T
Int J Dermatol; 2009 Apr; 48(4):379-87. PubMed ID: 19335423
[TBL] [Abstract][Full Text] [Related]
32. Biological variability of cholesterol, triglyceride, low- and high-density lipoprotein cholesterol, lipoprotein(a), and apolipoproteins A-I and B.
Marcovina SM; Gaur VP; Albers JJ
Clin Chem; 1994 Apr; 40(4):574-8. PubMed ID: 8149613
[TBL] [Abstract][Full Text] [Related]
33. Lipoprotein composition and serum Lp(a) lipoprotein in hypobetalipoproteinaemia.
Crook M; Swaminathan R
J Clin Pathol; 1995 Jun; 48(6):587-9. PubMed ID: 7665710
[TBL] [Abstract][Full Text] [Related]
34. The effect of change of renal replacement therapy on serum lipoprotein (a) concentration.
Misra M; Webb AT; Reaveley DA; Doherty E; O'Donnell M; Seed M; Brown EA
Adv Perit Dial; 1997; 13():168-73. PubMed ID: 9360675
[TBL] [Abstract][Full Text] [Related]
35. Effects of androgenic-anabolic steroids on apolipoproteins and lipoprotein (a).
Hartgens F; Rietjens G; Keizer HA; Kuipers H; Wolffenbuttel BH
Br J Sports Med; 2004 Jun; 38(3):253-9. PubMed ID: 15155420
[TBL] [Abstract][Full Text] [Related]
36. The effect of aggressive and moderate lowering of LDL-cholesterol and low dose anticoagulation on plasma lipids, apolipoproteins and lipoprotein families in post coronary artery bypass graft trial.
Alaupovic P; Fesmire JD; Hunnighake D; Domanski M; Forman S; Knatterud GL; Forrester J; Herd JA; Hoogwerf B; Campeau L; Gobel FL
Atherosclerosis; 1999 Oct; 146(2):369-79. PubMed ID: 10532693
[TBL] [Abstract][Full Text] [Related]
37. Effect of a new cyclical sequential postmenopausal HRT on lipoprotein, apoprotein and thrombophilia profile.
Habiba M; Akkad A; al-Azzawi F
Eur J Obstet Gynecol Reprod Biol; 1995 Sep; 62(1):89-94. PubMed ID: 7493716
[TBL] [Abstract][Full Text] [Related]
38. Serum lipid changes after estrogen therapy in prostatic carcinoma.
Bulusu NV; Lewis SB; Das S; Clayton WE
Urology; 1982 Aug; 20(2):147-50. PubMed ID: 7112817
[TBL] [Abstract][Full Text] [Related]
39. Effects of desogestrel and gestodene in low-dose oral contraceptive combinations on lipid and lipoprotein status. A randomized prospective study.
Granata A; Sobbrio GA; D'Arrigo F; Barillari M; Curasì MP; Egitto M; Trimarchi F; Granese D; Pullè C
Acta Eur Fertil; 1990; 21(3):143-6. PubMed ID: 2149913
[TBL] [Abstract][Full Text] [Related]
40. Lipoprotein(a) in alcohol-dependent male patients during a six-month abstinence period.
Budzyński J; Kłopocka M; Swiatkowski M; Pulkowski G; Ziółkowski M
Alcohol Alcohol; 2003; 38(2):157-62. PubMed ID: 12634264
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]